Validated clinical instruments with primary-source citations
PsychiatryAnxietyClinicians & PublicOpen Access / Terms Apply

GAD-7

Generalized Anxiety Disorder-7

Screens for generalized anxiety, measures symptom severity over time, and demonstrates good sensitivity for panic, social anxiety, and PTSD.

7 items·Estimated time: ~2 min·Evidence references below
Interactive Assessment
0 of 7 answered (0%)
Question 1 of 7

Feeling nervous, anxious, or on edge

Over the last 2 weeks, how often have you been bothered by this problem?

About the GAD-7

Validated 7-item instrument for screening and measuring the severity of generalized anxiety disorder.

Scoring Methodology & Interpretation

The GAD-7 uses a validated sum algorithm with predefined clinical cutoffs established in peer-reviewed derivation and validation cohorts:

Score RangeSeverity ClassificationClinical Interpretation
0 – 4Minimal Anxiety SymptomsScores 0–4 reflect absence of significant anxiety symptoms.
5 – 9Mild Anxiety SymptomsScores 5–9 indicate mild anxiety symptoms.
10 – 14Moderate Anxiety SymptomsScore 10 is the clinical cutoff (89% sensitivity, 82% specificity for GAD).
15 – 21Severe Anxiety SymptomsScores 15–21 indicate severe anxiety symptoms.

Clinical Pearls & Considerations

  • Score ≥ 10 identifies probable GAD; further evaluation is recommended to identify panic disorder or social phobia.
Copyright & Intellectual Property Attribution:

Developed by Drs. Robert L. Spitzer, Kurt Kroenke, Janet B.W. Williams and Bernd Löwe. Pfizer makes GAD-7 available without a formal permission request, subject to its published terms of use.

License: Review current Pfizer PHQ Screeners terms for the intended use
Clinical Disclaimer & Scope of Use

This instrument is designed for educational, informational, and clinical reference purposes. Screening scores do not constitute a definitive medical diagnosis. Individual clinical management must integrate full diagnostic history, physical examination, and laboratory data by a licensed healthcare professional.

  • Self-administered tool indicating symptom frequency; cannot establish an official psychiatric diagnosis.
  • Somatic anxiety symptoms should be differentiated from endocrine, cardiac, or substance-induced states.

Evidence & Primary Literature Citations

  1. Key Validation Study
    A brief measure for assessing generalized anxiety disorder: the GAD-7.
    Spitzer RL, Kroenke K, Williams JB, Löwe B. Arch Intern Med. 2006;166:1092-1097.

Related Validated Instruments